New York Times Hits SNFs, Again
The New York Times hit one of its favorite punching bags again with an article titled “Phony Diagnoses Hide High Rates of Drugging at Nursing Homes.” In it, the Times alleges that a loophole not requiring nursing homes to report antipsychotic prescriptions for three uncommon conditions, including schizophrenia, has led doctors associated with the facilities to false diagnose schizophrenia in patients with dementia. Since these patients require much more time and attention from an already overworked and underpaid staff, the Times reasons that SNFs would rather drug them than provide real dementia care. Some of the stats seemed damning. An analysis of Medicare data showed that schizophrenia... Read More »Webinar | Assisted Living: Was It Recession-Resistant After All? Where Are Values Now? | August 26, 2021
After census plunged 1,000 basis points across the country, has the assisted living recovery met expectations following the pandemic? Pent-up demand for this need-based product may have already exhausted itself, and rampant discounting would theoretically affect the cash flow recovery. Not only that, but the economic effects of the pandemic have hit communities differently, with “B” and “C” properties less financially flexible to meet rising wages, higher infection control costs and lower occupancy without a significant hit to their bottom lines. Investors have adapted to get deals done, propelling M&A activity to pre-pandemic heights this summer. But the properties they are targeting,... Read More »Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
